Wülfrath, Germany

Joachim Luithle

This inventor holds 32 USPTO granted patents and 4 published patent applications, plus 8 CIPO patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer Healthcare Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 2006-2019.

USPTO Granted Patents = 32 

% Patents Active = 15.6


Average Co-Inventor Count = 7.6

ph-index = 7

Forward Citations = 157(Granted Patents)


Location History:

  • Wüfrath, DE (2008)
  • Berlin, DE (2012 - 2017)
  • Wülfrath, DE (2006 - 2019)
  • Wulfrath, DE (2012 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Heteroaryl Carboxamides
Amides of Acetic Acids
Azabicyclic Carbamates
Alpha-7 Nicotinic Acetylcholine Receptor
N-Biarylamides
2-Heteroaryl Carboxamides
Morpoline-Bridged Indazole Derivatives
4-Amino-Substituted Pyrimidine Derivatives
Bicyclic N-Arylamides
Aza-Bicyclic N-Biarylamides
2,5-Disubstituted Pyrimidine Derivatives
32 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Joachim Luithle:

Title: Innovation Spotlight: Joachim Luithle - Pioneering Inventor from Wülfrath

Introduction:

Joachim Luithle, a renowned inventor hailing from Wülfrath, Germany, has left an indelible mark in the field of pharmaceutical innovations with his outstanding contributions.

Latest Patents:

With an impressive portfolio of 32 patents, Joachim Luithle's latest inventions showcase his expertise in the pharmaceutical industry. His patents on "Heteroaryl Carboxamides" and "Amides of Acetic and Propionic Acids" highlight novel compounds with applications in the treatment and prophylaxis of diseases, as well as in enhancing cognitive functions.

Career Highlights:

Having worked with prestigious companies such as Bayer Intellectual Property GmbH and Bayer Healthcare LLC, Joachim Luithle has played a pivotal role in driving innovation and advancing pharmaceutical research. His dedication to developing cutting-edge medicaments has garnered recognition from peers and industry experts alike.

Collaborations:

Collaborating with talented individuals like Christina Erb and Christoph Methfessel, Joachim Luithle has fostered a culture of innovation and excellence. Together, they have contributed towards groundbreaking discoveries that have the potential to transform healthcare and improve patient outcomes.

Conclusion:

In conclusion, Joachim Luithle's remarkable journey as an inventor underscores his commitment to pushing the boundaries of pharmaceutical science. His legacy of innovation serves as an inspiration for aspiring inventors and researchers worldwide, paving the way for a future filled with transformative discoveries and advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…